Analysis of protein induction in the CNS of SJL mice with experimental allergic encephalomyelitis by proteomic screening and immunohistochemistry.
Experimental allergic encephalomyelitis (EAE) is an autoimmune disease characterized by demyelination and inflammatory infiltrates in the CNS, and it is an animal model of multiple sclerosis. Piperonyl butoxide (PBO) suppresses disease in EAE mice, and it exhibits a dual effect on cytochrome P450s that manifests in a transient inhibitory phase followed by induction. In order to identify the expression of proteins associated with EAE, a proteomic screening was performed on hindbrain microsomes from control + vehicle, control + PBO, EAE + vehicle, and EAE + PBO female mice. Glucose regulated protein 94 (Grp94) and coagulation factor VIII were among the proteins identified in EAE + vehicle and EAE + PBO mice. Immunohistochemical staining of Grp94 was present in some neurons and oligodendrocytes in hindbrain sections from control animals, and in some cells within inflammatory infiltrates in EAE animals. Since Grp94 (also known as Gp96) can partake in antigen presentation and induction of proinflammatory cytokine expression, its presence in these cells suggests that it may play a role in the pathogenesis of EAE. Coagulation factor VIII is carried and protected by von Willebrand factor. Immunohistochemical staining of von Willebrand factor revealed its presence in some vessels within hindbrain sections from control animals. In EAE animals, the number of labeled vessels was significantly increased, and extracellular granular deposits were observed around labeled vessels indicating that the breakdown of the blood-brain barrier that occurs in EAE permitted its extravasation into the CNS. Additional proteins were identified in the different groups of mice by proteomic screening, but confirmation of their expression profile awaits investigations by independent measures.
Duzhak
T
T
Biochemical Research Service Laboratory, University of Kansas, Lawrence, Kansas 66045, USA.
Emerson
M R
MR
Chakrabarty
A
A
Alterman
M A
MA
LeVine
S M
SM
D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis; D002490:Central Nervous System / Q000737:chemistry* / Q000187:drug effects / Q000473:pathology; D030562:Databases, Protein; D004591:Electrophoresis, Polyacrylamide Gel; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006868:Hydrolysis; D007091:Image Processing, Computer-Assisted; D007150:Immunohistochemistry; D008526:Medulla Oblongata / Q000737:chemistry; D051379:Mice; D008861:Microsomes / Q000737:chemistry; D018991:Myelin Proteolipid Protein / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology; D010449:Peptide Mapping / Q000379:methods; D037342:Pertussis Toxin / Q000494:pharmacology; D010882:Piperonyl Butoxide / Q000494:pharmacology; D011149:Pons / Q000737:chemistry; D020543:Proteome / Q000032:analysis* / Q000302:isolation & purification; D012249:Rhombencephalon / Q000737:chemistry; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D014357:Trypsin / Q000378:metabolism; D014841:von Willebrand Factor / Q000032:analysis
D000951:Antigens, Neoplasm; D018991:Myelin Proteolipid Protein; D010446:Peptide Fragments; D020543:Proteome; C435023:myelin proteolipid protein (139-151); C052646:sarcoma glycoprotein gp96 rejection antigens; D014841:von Willebrand Factor; D037342:Pertussis Toxin; D014357:Trypsin; D010882:Piperonyl Butoxide